Recombinant human thyrotropin-assisted radioiodine therapy for patients with metastatic thyroid cancer who could not elevate endogenous thyrotropin or be withdrawn from thyroxine

Thyroid

Volumn 16, Issue 11, 2006, Pages 1121-1130

  Robbins, Richard J ^a,d   Driedger, Albert ^b   Magner, James ^c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c GENZYME CORPORATION   (United States)

^d Texas and the Task Force on the ACGME Competencies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROTROPIN; THYROXINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE PAIN; CANADA; CANCER GROWTH; CLINICAL TRIAL; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG USE; DYSPNEA; FEMALE; GASTROINTESTINAL DISEASE; HEALTH PROGRAM; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPOTHYROIDISM; INJECTION SITE PAIN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTICENTER STUDY; MUSCULOSKELETAL PAIN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RETROSPECTIVE STUDY; STRIDOR; SYMPTOM; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROTROPIN BLOOD LEVEL; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOTHYROIDISM; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PALLIATIVE CARE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SURVIVAL RATE; THYROID NEOPLASMS; THYROTROPIN; THYROXINE;

EID: 33845233817     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.16.1121     Document Type: Article

References (44)

1. 131I. In: Medeiros-Neto G, Gaitan E (eds) Frontiers in Thyroidology. Plenum Publishing Corp., New York, pp. 1317-1321.
2. Schlumberger M, Tubiana M, De Vathaire F, Hill C, Gardet P, Travagli J, Fragu P, Lumbroso J, Caillou B, Parmentier C 1986 Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 63:960-967.
3. Maxon HR, Thomas SR, Hertzberg VS, Kereiakes JG, Chen IW, Sperling MI, Saenger EL 1983 Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med 309:937-941.
4. Robeson WR, Ellwood JE, Margulies P, Margouleff D 2002 Outcome and toxicity associated with maximum safe dose radioiodine treatment of metastatic thyroid cancer. Clin Nucl Med 27:556-566.
5. Schlumberger MJ 1998 Papillary and follicular thyroid carcinoma. N Engl J Med 338:297-306.
6. Jaeschke R, Guyatt G, Cook D, Harper S, Gerstein HC 1994 Spectrum of quality of life impairment in hypothyroidism. Qual Life Res 3:323-327.
7. Dow K, Ferrell B, Anello C 1997 Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid 7:613-619.
8. Larisch R, Kley K, Nikolaus S, Sitte W, Franz M, Hautzel H, Tress W, Muller HW 2004 Depression and anxiety in different thyroid function states. Horm Metab Res 36:650-653.
9. Masiukiewicz US, Nakchbandi IA, Stewart AF, Inzucchi SE 1999 Papillary thyroid carcinoma metastatic to the pituitary gland. Thyroid 9:1023-1027.
10. Roberts CG, Ladenson PW 2004 Hypothyroidism. Lancet 363:793-803.
11. 131I and recombinant human thyroid stimulating hormone. J Clin Endocrinol Metab 82:11-14.
12. Abraham P, Sawyers H, Bevan J Follicular thyroid carcinoma presenting with a 10-centimetre pelvic metastasis: use of recombinant human TSH to facilitate radioiodine therapy. Proceedings of the 2nd Meeting of the British Thyroid Association, 1998. p. 6
13. Adler M, Macapinlac HA, Robbins RJ 1998 Radioiodine treatment of thyroid cancer with the aid of recombinant human thyrotropin. Endocr Pract 4:282-286.
14. Perros P 1999 Recombinant human thyroid-stimulating hormone (rhTSH) in the radioablation of well-differentiated thyroid cancer: Preliminary therapeutic experience. J Endocrinol Invest 22:30-34
15. Risse JH, Grunwald F, Bender H, Schuller H, Van Roost D, Biersack HJ 1999 Recombinant human thyrotropin in thyroid cancer and hypopituitarism due to sella metastasis. Thyroid 9:1253-1256.
16. Colleran KM, Burge MR 1999 Isolated thyrotropin deficiency secondary to primary empty sella in a patient with differentiated thyroid carcinoma: An indication for recombinant thyrotropin. Thyroid 9:1249-1252.
17. Robbins RJ, Voelker E, Wang W, Macapinlac HA, Larson SM 2000 Compassionate use of recombinant human thyrotropin to facilitate radioiodine therapy: Case report and review of literature. Endocr Pract 6:460-464.
18. Luster M, Lassmann M, Haenscheid H, Michalowski U, Incerti C, Reiners C 2000 Use of recombinant human thyrotropin before radioiodine therapy in patients with advanced differentiated thyroid carcinoma. J Clin Endocrinol Metab 85:3640-3645.
19. Luster M, Reinhardt W, Korber C, Lassmann M, Haenscheid H, Michalowski U, Rendl J, Eising E, Mann K, Reiners C 2000 The use of recombinant human TSH in a patient with metastatic follicular carcinoma and insufficient endogenous TSH production. J Endocrinol Invest 23:473-475.
20. Rotman-Pikielny P, Reynolds JC, Barker WC, Yen PM, Skarulis MC, Sarlis NJ 2000 Recombinant human thyrotropin for the diagnosis and treatment of a highly functional metastatic struma ovarii. J Clin Endocrinol Metab 85:237-244.
21. Basu A, Erickson D, Bahn R, Fatourechi V Use of recombinant human TSH (rhTSH) prior to radioiodine therapy in a case of hypopituitarism due to metastatic follicular thyroid cancer. The Endocrine Society 82nd Annual Meeting, 2000, p. 578
22. Mariani G, Ferdeghini M, Augeri C, Villa G, Taddei GZ, Scopinaro G, Boni G, Bodei L, Rabitti C, Molinari E, Bianchi R 2000 Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer. Cancer Biother Radiopharm 15:211-217.
23. Jarzab B, Handkiewicz-Junak D, Gawkowska-Suwinska M 2000 Recombinant human TSH in the diagnosis and treatment. Nucl Med Rev Cent East Eur 3:83-88.
24. Jarzab B, Roskosz J, Gawkowska-Suwinska M, Turska M, Handkiewicz-Junak D, Puch Z, Wygoda Z, Zajusz A 2000 Recombinant human TSH for the treatment of differentiated thyroid cancer metastatic to the spine. Nucl Med Rev Cent East Eur 3:157-160.
25. Aslam SN, Daly RG 2001 Use of recombinant human thyrotropin in a complicated case of metastatic papillary thyroid carcinoma. Endocr Pract 7:99-101.
26. Brans B, Gemmel F, De Winter O, Fiers T, De Roose J, Vermeersch H, Rubens R, Kaufman JM, Dierckx RA 2001 Recombinant humane thyrotropin (rhTSH) a new aid in the diagnosis and treatment of thyroid carcinoma with radioiodine. Acta Clin Belg 56:316-320.
27. Lippi F, Capezzone M, Angelini F, Taddei D, Molinaro E, Pinchera A, Pacini F 2001 Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH. Eur J Endocrinol 144:5-11.
28. Pellegriti G, Scollo C, Giuffrida D, Vigneri R, Squatrito S, Pezzino V 2001 Usefulness of recombinant human thyrotropin in the radiometabolic treatment of selected patients with thyroid cancer. Thyroid 11:1025-1030.
29. Graf H, Marone M, Almeida C 2001 Therapeutic use of recombinant TSH in 12 patients with differentiated thyroid carcinoma. Seventy-third Annual Meeting of the American Thyroid Association, p. 216
30. Berg G, Lindstedt G, Suurkula M, Jansson S 2002 Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone. J Endocrinol Invest 25:44-52
31. Muller V, Bohuslavizki KH, Klutmann S, Clausen M 2002 Value of recombinant human thyrotropin in high-dose radioiodine therapy: a case report. J Nucl Med Technol 30:185-188.
32. Robbins RJ, Larson SM, Pentlow KS, Tuttle RM 2003 Treatment of thyroid cancer metastases with 131-I following thyroid hormone withdrawal or recombinant human TSH. Thyroid 13:702.
33. Jarzab B, Handkiewicz-Junak D, Roskosz J, Puch Z, Wygoda Z, Kukulska A, Jurecka-Lubieniecka B, Hasse-Lazar K, Turska M, Zajusz A 2003 Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients. Eur J Nucl Med Mol Imaging 30:1077-1086.
34. Menzel C, Kranert WT, Dobert N, Diehl M, Fietz T, Hamscho N, Berner U, Grunwald F 2003 rhTSH stimulation before radioiodine therapy in thyroid cancer reduces the effective half-life of (131)I. J Nucl Med 44:1065-1068.
35. de Keizer B, Brans B, Hoekstra A, Zelissen PM, Koppeschaar HP, Lips CJ, van Rijk PP, Dierckx RA, de Klerk JM 2003 Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy. Eur J Nucl Med Mol Imaging 30:367-373.
36. Serafini AN, Clauss RP, Levis-Dusseau S 2003 Protocol for the combined diagnostic and therapeutic use of recombinant human thyroid-stimulating hormone. Clin Nucl Med 28:14-17.
37. Woodmansee WW, Haugen BR 2004 Uses for recombinant human TSH in patients with thyroid cancer and nodular goiter. Clin Endocrinol (Oxf) 61:163-173.
38. Driedger AA, Kotowycz N 2004 Two cases of thyroid carcinoma that were not stimulated by recombinant human thyrotropin. J Clin Endocrinol Metab 89:585-590.
39. Taieb D, Jacob T, Zotian E, Mundler O 2004 Lack of efficacy of recombinant human thyrotropin versus thyroid hormone withdrawal for radioiodine therapy imaging in a patient with differentiated thyroid carcinoma lung metastases. Thyroid 14:465-467.
40. Vargas GE, Uy H, Bazan C, Guise TA, Bruder JM 1999 Hemiplegia after thyrotropin alfa in a hypothyroid patient with thyroid carcinoma metastatic to the brain. J Clin Endocrinol Metab 84:3867-3871.
41. Goffman T, Ioffe V, Tuttle M, Bowers JT, Mason ME 2003 Near-lethal respiratory failure after recombinant human thyroid-stimulating hormone use in a patient with metastatic thyroid carcinoma. Thyroid 13:827-830.
42. Vitale G, Lupoli G, Ciccarelli A, Fonderico F, Klain M, Squame G, Salvatore M, Lupoli G 2002 The use of recombinant human TSH in the follow-up of differentiated thyroid cancer: Experience from a large patient cohort in a single centre. Clin Endocrinol 56:247-252.
43. Luster M, Lippi F, Jarzab B, Perros P, Lassmann M, Reiners C, Pacini F 2005 rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review. Endocr Relat Cancer 12:49-64.
44. Kohlfuerst S, Igerc I, Lind P 2005 Recombinant Human Thyrotropin is Helpful in the follow-up and (131) I therapy of patients with thyroid cancer: A report of the results and benefits using recombinant human thyrotropin in clinical routine. Thyroid 15:371-376.